Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: COVOO
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA Detection, Varies
Useful For 
Suggests clinical disorders or settings where the test may be helpful
Diagnosis of coronavirus disease 2019 (COVID-19) illness due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Recommended only for patients who meet current clinical and/or epidemiologic criteria defined by federal, state, or local public health directives.
Highlights
This test provides qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA from select upper respiratory tract specimens from patients under investigation (PUI) for coronavirus disease 2019 (COVID-19). Based on sequence analysis, it is predicted that this test will detect the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) variants.
This test ID combines various molecular assays designed for detection of SARS-CoV-2 into one orderable test. All of the assays used for testing have received emergency use authorization (EUA) from the FDA. Testing will be performed with 1 of the following assays:
-cobas SARS-CoV-2 (Roche Molecular Systems)
-PerkinElmer New Coronavirus Nucleic Acid Detection Kit (PerkinElmer, Inc.)
-ThermoFisher TaqPath COVID-19 Combo Kit (ThermoFisher Scientific, Inc.)
URL links to the fact sheets for each of these EUA assays are provided in the Method Description.
Reflex Tests Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests.
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| TATCH | TAT <=2 days additional charge | No, (Bill Only) | No |
Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
See Coronavirus Disease 2019 (COVID-19), Influenza, and Respiratory Syncytial Virus Testing Algorithm in Special Instructions.
In response to the new Centers for Medicare and Medicaid Services (CMS) payment strategy for coronavirus disease 2019 (COVID-19) diagnostic testing, a bill-only code will be added for orders that meet the new CMS turn-around-time requirement. For additional information refer to www.cms.gov/newsroom/press-releases/cms-changes-medicare-payment-support-faster-covid-19-diagnostic-testing.
Special Instructions Library of PDFs including pertinent information and forms related to the test
Method Name A short description of the method used to perform the test
Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)
NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reporting Name Lists a shorter or abbreviated version of the Published Name for a test
Aliases Lists additional common names for a test, as an aid in searching
COVID-19
COVID
SARS-CoV-2
SARS